SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

In a recent study posted to the medRxiv* pre-print server, researchers from the UK quantified the levels of specialized pro-resolving molecules (SPMs) and pro-inflammatory bioactive lipids in the serum of in-patients positive for severe acute respiratory syndrome 2 (SARS-CoV-2), and determined its correlation with immune responses and clinical outcomes. Study: Serum levels of specialised pro-resolving molecule pathways are greatly increased […]
Continue reading »